NovoCure Limited Ordinary Shares Share Price
NASDAQ: NVCRHealthcare
Live NovoCure Limited Ordinary Shares Share Price Chart
O H L
NovoCure Limited Ordinary Shares Performance Overview
Days Range
▼
$16.73Low
$16.84High
Markets Today
| Previous Close | $16.72 |
|---|---|
| Open | $16.80 |
| Volume | 140,628 |
| Day's Range | $16.73 - $16.84 |
| 52W Range | $9.82 - $21.45 |
| Market Cap | $1.89 B |
Historical Performance
| 1M Returns | -3.02 |
|---|---|
| 3M Returns | +17.09 |
| 6M Returns | +38.64 |
| 1Y Returns | +28.62 |
| 5Y Returns | -87.24 |
| 10Y Returns | +88.50 |
NovoCure Limited Ordinary Shares Fundamentals
| Market Cap | $1.89 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $655.35 M |
| ROE TTM | -0.39 |
| EPS TTM | $-1.31 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.59 |
| EBITDA | $-139.15 M |
| Profit Margin | -20.79 |
| Market Cap | $1.89 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $655.35 M |
| ROE TTM | -0.39 |
| EPS TTM | $-1.31 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.59 |
| EBITDA | $-139.15 M |
| Profit Margin | -20.79 |
NovoCure Limited Ordinary Shares Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $154.99 M | $158.81 M | $167.20 M | $174.35 M | $174.06 M | $183.58 M |
| Gross Profit + | $116.47 M | $117.33 M | $122.47 M | $132.19 M | $135.13 M | $142.48 M |
| Operating Income | -$37.87 M | -$39.52 M | -$36.02 M | -$40.39 M | -$67.42 M | -$10.56 M |
| EBITDA | -$34.54 M | -$36.08 M | -$32.36 M | -$36.17 M | -$63.30 M | -$6.25 M |
| Interest Expense | $0 | $4.54 M | $0 | $17.55 M | $0 | -$1.89 M |
| Depreciation | $3.33 M | $3.44 M | $3.66 M | $4.22 M | $4.12 M | $4.31 M |
| Income Before Tax | -$30.30 M | -$34.98 M | -$30.02 M | -$40.95 M | -$69.26 M | -$12.45 M |
| Income Tax Expense | $4.02 M | $5.16 M | $7.25 M | -$16.45 M | $1.88 M | $3.21 M |
| Net Income + | -$34.32 M | -$40.14 M | -$37.27 M | -$24.50 M | -$71.14 M | -$15.66 M |
| Net Profit Margin | -22.14% | -25.28% | -22.29% | -14.05% | -40.87% | -8.53% |
NovoCure Limited Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 | $0 | $0 |
| Reserve & Surplus | -$1.19 B | -$1.23 B | -$1.27 B | -$1.29 B | -$1.37 B | -$1.38 B |
| Non-Current Liabilities | $143.55 M | $146.80 M | $243.85 M | $240.63 M | $239.63 M | $236.39 M |
| Current Liabilities | $743.30 M | $749.63 M | $776.01 M | $223.23 M | $217.58 M | $220.71 M |
| Total Liabilities | $886.85 M | $896.43 M | $1.02 B | $463.86 M | $457.21 M | $457.10 M |
| Fixed Assets | $96.51 M | $98.92 M | $100.53 M | $99.67 M | $99.59 M | $101.95 M |
| Current Assets | $1.09 B | $1.08 B | $1.20 B | $646.73 M | $631.66 M | $638.52 M |
| Total Assets | $1.25 B | $1.25 B | $1.36 B | $804.33 M | $787.93 M | $795.19 M |
NovoCure Limited Ordinary Shares Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$34.32 M | -$40.14 M | -$37.27 M | -$24.50 M | -$71.14 M | -$15.66 M |
| Operating Cash Flow | -$35.66 M | -$15.94 M | $20.57 M | -$18.00 M | -$13.52 M | $8.13 M |
| Investing Cash Flow | -$6.47 M | $35.99 M | $71.44 M | $336.33 M | $7.75 M | -$6.38 M |
| Financing Cash Flow | $5.25 M | $2.39 M | $100.52 M | -$559.49 M | -$166.00 K | $4.55 M |
| Change in Cash | -$36.66 M | $22.70 M | $192.50 M | -$241.25 M | -$6.07 M | $6.29 M |
NovoCure Limited Ordinary Shares Return Calculator
The NovoCure Limited Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,276
Invested Amount$10,000
Est. Returns$-8,724
About NovoCure Limited Ordinary Shares
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Popular Stocks
FAQs
What is the share price of NovoCure Limited Ordinary Shares today?
NovoCure Limited Ordinary Shares (NVCR) share price as of September 18, 2026 is $16.72. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of NovoCure Limited Ordinary Shares?
Yes, Indian Investors can invest in the NovoCure Limited Ordinary Shares (NVCR) Share by opening an international trading account with Angel One.
How can I purchase NovoCure Limited Ordinary Shares shares in India?
Purchasing NovoCure Limited Ordinary Shares (NVCR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying NovoCure Limited Ordinary Shares (NVCR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of NovoCure Limited Ordinary Shares?
Yes, you can purchase fractional shares of NovoCure Limited Ordinary Shares (NVCR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of NovoCure Limited Ordinary Shares?
The market capitalization of NovoCure Limited Ordinary Shares on September 18, 2026, is $1.89 B.
In which sector NovoCure Limited Ordinary Shares belongs?
NovoCure Limited Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in NovoCure Limited Ordinary Shares stocks?
In order to invest in NovoCure Limited Ordinary Shares (NVCR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
